# levothyroxine sodium

NDC: 51655-727
Generic name: levothyroxine sodium
Labeler / Manufacturer: Northwind Health Company, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210611

FDA application: NDA021116

## Active ingredients

- LEVOTHYROXINE SODIUM: 150 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51655-727"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51655-727
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db89c58f-9dd0-b6d6-e053-2a95a90ae2e7